Phenotypic and functional characterization of freshly isolated and expanded canine regulatory T cells

Experimental Animals

Volumn 60, Issue 5, 2011, Pages 471-479

  Knueppel, Anne ^a   Lange, Sandra ^a   Sekora, Anett ^a   Altmann, Simone ^a   Freund, Mathias ^a   Junghanss, Christian ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Dogs; Enrichment; Expansion; Lymphocyte proliferation; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; DOG; EFFECTOR CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNE DISEASES; CELL SEPARATION; CELLS, CULTURED; DOGS; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY, CELLULAR; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; NEOPLASMS; PHENOTYPE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

CANIS FAMILIARIS; ERAGROSTIS TEF;

EID: 80155190353     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.60.471     Document Type: Article

References (43)

1. Abrams, V.K., Hwang, B., Lesnikova, M., Gass, M.J., Wayner, E., Castille-Llorente, C., Georges, G., and Nash, R.A. 2010. A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs. Vet. Immunol. Immunopathol. 135: 257-265.
2. Asanuma, S., Tanaka, J., Sugita, J., Kosigu, M., Shiratori, S., Wakasa, K., Shono, Y., Shigematsu, A., Kondo, T., Kobayashi, T., Asaka, M., and Imamura, M. 2010. Expansion of CD4(+)CD25(+) regulatory T cells from cord blood CD4(+) cells using the common g-chain cytokines (IL-2 and IL-15) and rapamycin. Ann. Hematol. [Epub ahead of print].
3. Baecher-Allan, C. and Anderson, D.E. 2006. Regulatory cells and human cancer. Semin. Cancer Biol. 16: 98-105.
4. Banerjee, D., Dhodapkar, M.V., Matayeva, E., Steinman, R.M., and Dhodapkar, K. 2006. Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine maturated DCs in myeloma patients. Blood 108: 2655-2661.
5. Battaglia, M., Stabilini, A., and Roncardo, M.G. 2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 105: 4743-4748
6. Beyer, M. and Schultze, J.L. 2006. Regulatory T cells in cancer. Blood 108: 804-811.
7. Biller, B.J., Elmslie, R.E., Burnett, R.C., Avery, A.C., and Dow, S.W. 2007. Use of Foxp3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet. Immunol. Immunopathol. 116: 69-78.
8. Bopp, T., Becker, C., Klein, M., Klein-Heßling, S., Palmetshofer, A., Serfling, E., Heib, V., Becker, M., Kubach, J., Schmitt, S., Stoll, S., Schild, H., Staege, M.S., Stassen, M., Jonuleit, H., and Schmitt, E. 2007. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J. Exp. Med. 204: 1303-1310.
9. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., and Demengeot, J. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 397-401.
10. Chai, J.-G., Coe, D., Chen, D., Simpson, E., Dyson, J., and Scott, D. 2008. In vitro expansion improves in vivo regulation by CD4+CD25+ regulatory T cells. J. Immunol. 180: 858-869.
11. Dejaco, C., Duftner, C., and Grubeck-Loebenstein, B. 2005. Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117: 289-300.
12. Enghard, P. and Riemekasten, G. 2003. Regulatorische T-Zellen - ein mögliches Ziel zur Behandlung von systemischen Autoimmunerkrankungen. Z. Rheumatol. 62: 355-360 (in German).
13. Fehérvari, Z. and Sakaguchi, S. 2004. CD4+ Tregs and immune control. J. Clin. Invest. 114: 1209-1217.
14. Feng, X., Kajigaya, S., Solomou, E.E., Keyvanfar, K., Xu, X., Raghavachari, N., Muson, P.J., Herndon, T.M., Chen, J., and Young, N.S. 2008. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 111: 3675-3683.
15. Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
16. Furtado, G.C., Curotto de Lafaille, M.A., Kutchukhizde, N., and Lafaille, J.J. 2002. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196: 851-857.
17. Gansuvd, B., Asiedu, C.K., Goodwin, J., Jargal, U., Deckard, L.A., Andrades, P., Guarcello, V., and Thomas, J.M. 2007. Expansion of CD4+CD25+ suppressive regulatory T cells from Rhesus macaque peripheral blood by Fn18/anti-human CD28 coated Dynal beads. Hum. Immunol. 68: 478-490.
18. Grossmann, W.J., Verbsky, J.W., Barchet, W., Colonna, M., Atkinson, J.P., and Ley, T.J. 2004. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589-601.
19. Ha, T.Y. 2009. The role of regulatory T cells in cancer. Immune Netw. 9: 209-235.
20. Hori, S., Nomura, T., and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
21. Kolb, H.J., Günther, W., Schumm, M., Holler, E., Wilmanns, W., and Thierfelder, S. 1997. Adoptive immunotherapy in canine chimeras. Transplantation 63: 430-436.
22. Linehan, D.C. and Goedegebuure, P.S. 2005. CD25+CD4+ regulatory T-cells in cancer. Immunol. Res. 32: 155-168
23. Maloy, K.J. and Powrie, F. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2: 816-822.
24. Maris, M., Sandmaier, B.M., Maloney, D.G., McSweeney, P.A., Woolfrey, A., Chauncey, T., Shizuru, J., Niederwieser, D., Blume, K.G., Forman, S., and Storb, R. 2001. Non-myeloablative hematopoietic stem cell transplantation. Transfus. Clin. Biol. 8: 231-234.
25. Mizuno, T., Suzuki, R., Umeki, S., and Okuda, M. 2009. Crossreactivity of antibodies to canine CD25 and Foxp3 and identification of canine CD4+CD25+Foxp3+ cells in canine peripheral blood. J. Vet. Med. Sci. 71: 1561-1568.
26. Nagahama, K., Nishimura, E., and Sakaguchi, S. 2007. Induction of tolerance by adoptive transfer of Treg cells. Methods Mol Biol. 380: 431-442.
27. O'Neill, K., Guth, A., Biller, B., Elmslie, R., and Dow, S. 2009. Changes in regulatory T cells in dogs with cancer and associations with tumor type. J. Vet. Intern. Med. 23: 875-881.
28. Pandiyan, P. 2007. Isolation of Treg cells and Treg cell suppression/death assay. Nat. Protoc. (in press).
29. Papiernik, M., de Moeras, M.L., Pontoux, C., Vasseur, F., and Penit, C. 1998. Regulatory CD4 T cells: expression of IL-2Ra chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10: 371-378.
30. Pfoertner, S., Jeron, A., and Probst-Kepper, M. 2006. Signatures of human regulatory T cells: an encounter with old friends and new players. Genome Biol. 7: R54.
31. Pinheiro, D., Singh, Y., Grant, C.R., Appleton, R.C., Sacchini, F., Walker, K.R.L., Chadbourne, A.H., Palmer, C.A., Armitage-Chan, E., Thompson, I., Williamson, L., Cunningham, F., and Garden, O.A. 2010. Phenotypic and functional characterization of a CD4+CD25highFOXP3high regulatory T-cell population in the dog. Immunology 132: 111-122
32. Porter, C.M., Horvath-Arcidiacono, J.A., Singh, A.K., Horvath, K.A., Bloom, E.T., and Mohiuddin, M.M. 2007. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model. Xenotransplantation 14: 298-308
33. Qin, H.J., Mukherjee, R., Lee-Chan, E., Ewen, C., Bleackley, R.C., and Singh, B. 2006. A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int. Immunol. 18: 1001-1015.
34. Ring, S., Thome, M., Pretsch, L., Enk, A.H., and Mahnke, K. 2007. Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions. J. Immunol. Methods. 326: 10-21.
35. Rissetto, K.C., Rindt, H., Selting, K.A., Villamil, J.A., Henry, C.J., and Reinero, C.R. 2010. Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma. Vet. Immunol. Immunopathol. 15: 137-145.
36. Stephens, L.A., Mottet, C., Mason, D., and Powrie, F. 2001. Human CD4+ CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 165: 3105-3110.
37. Tang, Q. and Bluestone, J.A. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244.
38. Vignali, D.A.A., Collison, L.W., and Workman, C.J. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
39. Walker, L.S.K. 2004. CD4+CD25+ Treg: divide and rule? Immunology 111: 129-137.
40. Xia, G., He, J., and Leventhal, J.R. 2008. Ex Vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am. J. Transplant. 8: 298-306.
41. Yamazaki, S., Patel, M., Harper, A., Bonito, A., Fukuyama, H., Pack, M., Tarbell, K.V., Talmor, M., Ravetch, J.V., Inaba, K., and Steinman, R.M. 2006. Effective expansion of alloantigen-specific Foxp3+CD25+CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. U.S.A. 103: 2758-2763.
42. Zelenay, S., Lopes-Carvalho, T., Caramalho, I., Moraes-Fontes, M.F., Rebelo, M., and Demengeot, J. 2005. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression under homeostatic expansion. Proc. Natl. Acad. Sci. U.S.A. 102: 4091-4096.
43. Zorn, E., Nelson, E.A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R.J., Frank, D.A., and Ritz, J. 2006. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-1579.